Roth Capital Trims SenesTech (SNES) Target Price to $14.00

SenesTech (NASDAQ:SNES) had its price target reduced by Roth Capital from $3.75 to $14.00 in a research note issued to investors on Thursday. They currently have a buy rating on the stock.

Several other research analysts also recently commented on SNES. Zacks Investment Research downgraded shares of SenesTech from a hold rating to a sell rating in a research note on Tuesday, October 3rd. Craig Hallum set a $3.00 price objective on shares of SenesTech and gave the company a buy rating in a research report on Wednesday, November 22nd.

SenesTech (NASDAQ SNES) opened at $0.72 on Thursday. The company has a current ratio of 2.94, a quick ratio of 2.67 and a debt-to-equity ratio of 0.17. SenesTech has a one year low of $0.56 and a one year high of $10.69.

SenesTech (NASDAQ:SNES) last issued its earnings results on Wednesday, November 8th. The company reported ($0.28) EPS for the quarter, topping the consensus estimate of ($0.31) by $0.03. SenesTech had a negative net margin of 14,473.40% and a negative return on equity of 190.41%. The company had revenue of $0.02 million for the quarter, compared to the consensus estimate of $0.25 million. research analysts forecast that SenesTech will post -1.16 EPS for the current year.

A number of institutional investors have recently modified their holdings of the business. Gilder Gagnon Howe & Co. LLC increased its position in SenesTech by 3.0% during the 3rd quarter. Gilder Gagnon Howe & Co. LLC now owns 1,078,499 shares of the company’s stock valued at $1,995,000 after purchasing an additional 31,330 shares during the period. TCI Wealth Advisors Inc. purchased a new position in SenesTech during the 3rd quarter valued at $748,000. Skylands Capital LLC increased its position in SenesTech by 139.8% during the 3rd quarter. Skylands Capital LLC now owns 87,483 shares of the company’s stock valued at $162,000 after purchasing an additional 51,000 shares during the period. Prudential PLC increased its position in SenesTech by 49.3% during the 2nd quarter. Prudential PLC now owns 447,971 shares of the company’s stock valued at $2,661,000 after purchasing an additional 147,971 shares during the period. Finally, White Pine Capital LLC purchased a new position in SenesTech during the 2nd quarter valued at $110,000. 14.44% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Roth Capital Trims SenesTech (SNES) Target Price to $14.00” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece on another publication, it was illegally copied and republished in violation of U.S. and international copyright laws. The original version of this piece can be viewed at https://stocknewstimes.com/2017/12/31/roth-capital-trims-senestech-snes-target-price-to-14-00.html.

SenesTech Company Profile

SenesTech, Inc is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest’s technology and approach targets the reproductive capabilities of both sexes.

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply